You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.

Kedrion Mexicana, a subsidiary of Kedrion Biopharma, based in Castelvecchio Pascoli (Lucca, Italy), specializes in providing highest quality, plasma-derived products to the Mexican market. 

Kedrion established its presence in Mexico in 2008, when it created a joint venture (60% Kedrion-owned) with the Ramos family, who have had a long and respected history in the Mexican pharmaceutical sector.

Entrance into the Mexican market began with Kedrialb® (Human Albumin), followed by Kedrigamma® (Human Intravenous Immunoglobulin), KeyRho® (Anti RH Immunoglobulin), KedriFIX ®(Plasma Derived FIX) and the recently launched Plasmaclot® (Plasma Derived FVIII).  The company has become a trusted supplier for IMSS and ISSSTE, the main Public Health Institutes. All of our products are produced in Italy.

Kedrion Mexicana is proud of its reputation as a trustworthy and reliable partner to Mexico’s healthcare system.

We are committed to promoting broader access to treatments for rare disorders and believes that the most effective way to achieve this is to provide useful and important information to physicians, patients and authorities.

Kedrion around the world

Kedrion Biopharma has a long history of collaboration with the Italian National Health System, and partners the country in its move toward self-sufficiency in plasma-derived products. We bring this experience and the dedication to that goal to potential partners around the world. In recent years Kedrion has expanded its operations – not only into the United States through Kedrion Biopharma Inc., but into Hungary as well. It now has a market presence in about 100 countries. In addition, it has acquired collection and production capacity as well as the rights to significant products for treating hemophilia and preventing Rh sensitization, a condition which can lead to Hemolytic Disease of the Fetus and the Newborn (HDFN).

Kedrion looks forward to continued expansion and the wider sharing of its experience, know-how and technology to foster self-sufficiency of plasma-derived products in healthcare systems and communities around the world and to bring healthier and less restricted lives to people suffering from rare disorders.


Everyone has the right to life, liberty and security of person*

Sometimes, natural, accidental or social causes obstruct the natural right to life, liberty and personal security. Because of the special nature of its products, Kedrion supports people, communities and institutions in reducing or removing those obstacles that prevent people enjoying such rights. Kedrion helps turn the natural rights (life, liberty, security) into the social right to live in the best possible conditions.

For this reason, it collects and converts, makes active and usable that vital energy that is generated and regenerated, preserved and carried through blood; so that it can be transferred from one human being to the next, and anyone can enjoy one’s fundamental rights.

*Universal Declaration of Human Rights, art. 3.

Our mission

Kedrion editorial media

Kedrion produces and distributes human plasma-derived medicinal products used to treat and prevent rare and debilitating diseases and disorders.  Kedrion works to maintain excellent industry standards and aspires to ongoing improvement, in order to retain a leading position in Italy and to increase its share of the international market. It works to strengthen its role as the accredited partner of the medical, scientific and institutional communities. 

Kedrion’s ambition is to enhance its worldwide role as a strategic partner of the national health systems of those countries which aim to become self-sufficient in the availability of plasma-derived products, also via technology transfer.

Kedrion produces wealth for investors, employees and for the local community, consistently with its own vision and values: responsibility, transparency, confidence in and respect for people.



To act as responsible global citizens respecting all the communities with whom and for whom we work.


To make accurate and comprehensive information available to all stakeholders.


To demonstrate care and respect for our clients, our collaborators and our employees by continuous emphasis on the quality and safety of all our products and processes.